-The Times of India The Supreme Court on Monday rejected pharma giant Novartis AG's plea to preserve its patent over a life-saving cancer drug, Glivec, drawing a huge sigh of relief from thousands of patients in India and in dozens of developing countries as the fear of an almost 15-fold escalation of drug costs receded. It is the biggest setback for multinational pharma companies, which have been denied patent protection...
More »SEARCH RESULT
SC verdict on Novartis AG plea today
-Reuters Global drugmakers, battered by recent intellectual property decisions in the country, are girding for a landmark court ruling on Monday with broad consequences for their ability to sell lucrative patented medicines in the country. Supreme Court is due to decide on April 1 whether or not Swiss giant Novartis AG's cancer treatment Glivec deserves a patent in the country. "Big Pharma is nervous because nothing has gone in their favour in the...
More »Justice Big Mouth- Rahul Kotiyal and Ajachi Chakrabarti
-Tehelka A public issue is not truly public unless Markandey Katju has passed judgement. Rahul Kotiyal and Ajachi Chakrabarti stand downwind "Journalists" writes Markandey Katju, with little sense of irony, "comment on everything under the sun." He goes on to say that when the shoe is on the other foot, when someone comments on journalism, it is misconstrued as an attack on press freedom. That when he announces he is appointing a...
More »Only 7% of schools meet RTE deadline-Darshana Ramdev
-Deccan Chronicle Bengaluru: Today, the deadline for compliance with the infrastructure requirements of the Right to Education Act expires, but astoundingly, only 7 per cent of schools across the country meet the eligibility criteria. This means that over 3,00,000 private schools across the country are looking at closure once the deadline has passed, according to the Act. This means that nearly five crore students will be out of school. According to...
More »A scheme for the poor, not a poor scheme-Neelakshi Mann and Varad Pande
-The Indian Express Of late, there has been much public debate around the effectiveness of the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA), particularly on its targeting of the poor and the socioeconomic profile of its beneficiaries (most notably in this newspaper). It is important to look at these claims closely, not as much to counter them but as to present the real picture that has been undermined by often-unsubstantiated...
More »